BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 21600205)

  • 21. Both Hepatitis C Virus-Specific T Cell Responses and IL28B rs12979860 Single-Nucleotide Polymorphism Genotype Influence Antihepatitis C Virus Treatment Outcome in Patients with Chronic Hepatitis C.
    Benito JM; García-Samaniego J; García M; Madejón A; Martín-Carbonero L; Cabello A; Álvarez B; Górgolas M; Rallón N
    J Interferon Cytokine Res; 2017 Jun; 37(6):278-286. PubMed ID: 28440692
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IL28B gene polymorphisms and US liver fatty changes in patients who spontaneously cleared hepatitis C virus infection.
    Taliani G; Spaziante M; Biliotti E; Borro M; Palazzo D; Grieco S; Franchi C; Iaiani G; Furlan C; Gallinaro V; Simmaco M
    PLoS One; 2013; 8(8):e67301. PubMed ID: 23936294
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interleukin-28B rs12979860C/T and rs8099917T/G contribute to spontaneous clearance of hepatitis C virus in Caucasians.
    Zheng MH; Li Y; Xiao DD; Shi KQ; Fan YC; Chen LL; Liu WY; Luo YW; Chen YP
    Gene; 2013 Apr; 518(2):479-82. PubMed ID: 23266640
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interleukin-28B genetic variations and spontaneous clearance of hepatitis C antibody-positive blood donors in China.
    Liu Y; Ma H; Chen S; Wang J; Liu G; Xu M; Ke L; He M
    Transfusion; 2013 Oct; 53(10 Pt 2):2498-504. PubMed ID: 23782163
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impact of genetic variation in IL28B, IFNL4 and HLA genes on treatment responses against chronic hepatitis C virus infection.
    Sakhaee F; Ghazanfari M; Vaziri F; Jamnani FR; Davari M; Gharibzadeh S; Fateh R; Abdolrahimi F; Dizaji SP; Fateh A; Siadat SD
    Infect Genet Evol; 2017 Oct; 54():330-337. PubMed ID: 28739427
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association between IL28B gene polymorphisms and plasma HCV-RNA levels in HIV/HCV-co-infected patients.
    Labarga P; Soriano V; Caruz A; Poveda E; Di Lello FA; Hernandez-Quero J; Moreno S; Bernal E; Miró JM; Leal M; Gutierrez F; Portilla J; Pineda JA;
    AIDS; 2011 Mar; 25(6):761-6. PubMed ID: 21378537
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of the relationship between IL28B, IL10RB and IL28RA single-nucleotide polymorphisms and susceptibility to hepatitis C virus in Chinese Han population.
    Jin G; Kang H; Chen X; Dai D
    Infect Genet Evol; 2014 Jan; 21():8-14. PubMed ID: 24144988
    [TBL] [Abstract][Full Text] [Related]  

  • 28. KIR, HLA, and IL28B variant predict response to antiviral therapy in genotype 1 chronic hepatitis C patients in Japan.
    Nozawa Y; Umemura T; Joshita S; Katsuyama Y; Shibata S; Kimura T; Morita S; Komatsu M; Matsumoto A; Tanaka E; Ota M
    PLoS One; 2013; 8(12):e83381. PubMed ID: 24349500
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IL28B genetic variants and gender are associated with spontaneous clearance of hepatitis C virus infection.
    Rao HY; Sun DG; Jiang D; Yang RF; Guo F; Wang JH; Liu F; Zhang HY; Zhang HH; Du SC; Jin Q; Qin H; Lok AS; Wei L
    J Viral Hepat; 2012 Mar; 19(3):173-81. PubMed ID: 22329371
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of Thymine--Adenine Dinucleotide Repeat, IL28B and IFNL4 in Thai Population and Correlation with Spontaneous Clearance and Treatment Outcome of Hepatitis C Infection.
    Thong VD; Wasitthankasem R; Tangkijvanich P; Vongpunsawad S; Poovorawan Y
    PLoS One; 2015; 10(5):e0125400. PubMed ID: 25938236
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Strong prediction of virological response to combination therapy by IL28B gene variants rs12979860 and rs8099917 in chronic hepatitis C genotype 4.
    Ragheb MM; Nemr NA; Kishk RM; Mandour MF; Abdou MM; Matsuura K; Watanabe T; Tanaka Y
    Liver Int; 2014 Jul; 34(6):890-5. PubMed ID: 24102823
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of two polymorphisms of the IL28B gene with viral factors and treatment response in 1,518 patients infected with hepatitis C virus.
    Kobayashi M; Suzuki F; Akuta N; Sezaki H; Suzuki Y; Hosaka T; Kawamura Y; Kobayashi M; Saitoh S; Arase Y; Ikeda K; Chayama K; Miyakawa Y; Kumada H
    J Gastroenterol; 2012 May; 47(5):596-605. PubMed ID: 22438096
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IL28B polymorphism and cytomegalovirus predict response to treatment in Egyptian HCV type 4 patients.
    El Awady MK; Bader El Din NG; Tabll A; El Hosary Y; Abdel Aziz AO; El Khayat H; Salama M; Abdelhafez TH
    World J Gastroenterol; 2013 Jan; 19(2):290-8. PubMed ID: 23345953
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic variation in interleukin 28B with respect to vertical transmission of hepatitis C virus and spontaneous clearance in HCV-infected children.
    Ruiz-Extremera A; Muñoz-Gámez JA; Salmerón-Ruiz MA; de Rueda PM; Quiles-Pérez R; Gila-Medina A; Casado J; Belén Martín A; Sanjuan-Nuñez L; Carazo A; Pavón EJ; Ocete-Hita E; León J; Salmerón J
    Hepatology; 2011 Jun; 53(6):1830-8. PubMed ID: 21413051
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of IL28B rs12979860 CC genotype on metabolic profile and sustained virologic response in patients with genotype 1 chronic hepatitis C.
    Petta S; Rosso C; Leung R; Abate ML; Booth D; Salomone F; Gambino R; Rizzetto M; Caviglia P; Smedile A; Grimaudo S; Cammà C; Craxì A; George J; Bugianesi E
    Clin Gastroenterol Hepatol; 2013 Mar; 11(3):311-7.e1. PubMed ID: 23220171
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlation of IL28B rs12979860 genotype and gender with spontaneous clearance of HCV infection: a Pakistani cross-section study.
    Ali Q; Jamal A; Imran M; Ullah S; Kalam I; Ullah S; Waqar AB
    Per Med; 2018 Nov; 15(6):495-502. PubMed ID: 30398404
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polymorphisms in EGFR and IL28B are associated with spontaneous clearance in an HCV-infected Iranian population.
    Carapito R; Poustchi H; Kwemou M; Untrau M; Sharifi AH; Merat S; Haj-Sheykholeslami A; Jabbari H; Esmaili S; Michel S; Toussaint J; Le Gentil M; Ansari-Moghaddam A; Radosavljevic M; Etemadi A; Georgel P; Malekzadeh R; Bahram S
    Genes Immun; 2015 Dec; 16(8):514-8. PubMed ID: 26378651
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HCV RNA levels in a multiethnic cohort of injection drug users: human genetic, viral and demographic associations.
    Uccellini L; Tseng FC; Monaco A; Shebl FM; Pfeiffer R; Dotrang M; Buckett D; Busch MP; Wang E; Edlin BR; Marincola FM; O'Brien TR
    Hepatology; 2012 Jul; 56(1):86-94. PubMed ID: 22331649
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IL28B polymorphism as a predictor of antiviral response in chronic hepatitis C.
    Cieśla A; Bociąga-Jasik M; Sobczyk-Krupiarz I; Głowacki MK; Owczarek D; Cibor D; Sanak M; Mach T
    World J Gastroenterol; 2012 Sep; 18(35):4892-7. PubMed ID: 23002361
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Host and viral determinants of the outcome of exposure to HCV infection genotype 4: a large longitudinal study.
    Kamal SM; Kassim SK; Ahmed AI; Mahmoud S; Bahnasy KA; Hafez TA; Aziz IA; Fathelbab IF; Mansour HM
    Am J Gastroenterol; 2014 Feb; 109(2):199-211. PubMed ID: 24445571
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.